We therefore suggest that the whole FOXM1-AKT feedback loop is involved in AML venetoclax sensitivity regulation, while disruption of this loop at any point (AKT, FOXM1, or intermediate regulators) may help to overcome drug resistance. Here, AKT1 is linked to acute myeloid leukemia.